Quidel | QDEL - Ebitda



金融业
股票价格
USD
资产
USD 5.72B
现金及等价物
USD 123.4M
销售成本
USD 407M
流动资产
USD 1.38B
流动负债
USD 993.4M
债务
USD 2.87B
EBIT
USD -15.3M
EBITDA
USD 129.3M
员工
6.6K
EPS每股收益
USD -1.27
股本和储备
USD 1.85B
销售毛利
USD 223.9M
债务利息支出
USD 5.63B
利息收入
USD -1.35
贷款资金
USD 2.54B
市值
USD 1.09B
净收入
USD -92.9M
营业费用
USD 646.2M
营业利润
USD -15.3M
普通股股本
USD 68.1M
PE价格收益
2.03
税前利润
USD -79.5M
销售收入
USD 630.9M
销售和管理费用
USD 189.7M
股票
USD 618.9M
贸易债权人
USD 236.5M
应收帐款人
USD 352M


Ebitda 更改 日
Abbott USD 2.43B 844M 2026-03
Agilent USD 456M 84M 2025-12
Becton, Dickinson and Co. USD 1.71B 1B 2026-06
Bruker USD 143.2M 33.2M 2026-06
Charles River Laboratories USD 272.95M 43.14M 2026-06
Danaher USD 1.84B 81M 2026-06
Haemonetics USD 96.17M 91.87M 2026-06
Illumina USD 330M 80M 2026-06
IQVIA Holdings USD 994M 62M 2026-06
Merit Medical Systems USD 104.39M 10.97M 2026-06
Mettler Toledo International USD 322.64M 43.66M 2026-06
Myriad Genetics USD 14.3M 4M 2025-12
Neogen USD 45.4M 2.8M 2026-03
OraSure Technologies USD -17.7M 4.06M 2025-12
Pacific Biosciences Of California USD -35.4M 5.78M 2025-09
Quidel USD 129.3M 20.6M 2026-06
Revvity USD 228.18M 44.73M 2026-06
STAAR Surgical USD -159K 34.78M 2025-12
Thermo Fisher Scientific USD 3.55B 845M 2026-06
Waters USD 712M 545M 2026-06